A controlled trial of ambroxol in chronic bronchitis.
作者信息
Guyatt G H, Townsend M, Kazim F, Newhouse M T
机构信息
Department of Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, Ontario, Canada.
出版信息
Chest. 1987 Oct;92(4):618-20. doi: 10.1378/chest.92.4.618.
PMID:3308343
Abstract
Ambroxol is a mucolytic agent which is widely used in chronic bronchitis in Europe. We conducted a double-blind randomized controlled trial of ambroxol vs matched placebo in 90 patients with chronic bronchitis and difficulty clearing secretions. It was concluded that there was no advantage to taking ambroxol.
摘要
Zotero 插件